What is ISO 15197?

ISO 15197:2013 lays out the performance requirements and user safety criteria for blood-glucose monitoring systems intended for self-testing by patients with diabetes mellitus. It defines precision metrics, system accuracy, usability guidelines, and labelling requirements to ensure consistency, reliability, and effectiveness in real-world usage.

The standard also mandates stringent evaluation methods, including clinical trials and analytical performance assessments, to verify the accuracy of the test results across a range of glucose concentrations.

Growth Management Corporation offers end-to-end consulting services—gap assessment, documentation support, risk management planning, and audit readiness—to help you achieve ISO 15197 certification quickly and efficiently.

Why is ISO 15197 important?

ISO 15197:2013 certification is essential for manufacturers of blood-glucose monitoring systems who want to access international markets and comply with healthcare regulations such as IVDR (In Vitro Diagnostic Regulation) in the EU or US FDA guidelines.

Failing to meet ISO 15197 can result in market rejections, legal issues, and patient safety concerns. Choosing this standard is not just a regulatory need—it's a commitment to quality and user health.

What are the benefits of ISO 15197?

  1. Global Recognition: ISO 15197 certification boosts your product’s credibility across regulated markets like Europe, Asia, and the U.S.
  2. Improved Product Accuracy: Ensures the device provides precise blood-glucose readings in real-world conditions.
  3. Enhanced Patient Safety: Reduces risks associated with inaccurate glucose readings and supports better diabetes management.
  4. Standardized Testing Protocols: Ensures uniformity in testing procedures and documentation.
  5. Compliance with IVDR & MDR: Aligns with EU’s evolving medical device regulatory framework.
  6. Supports CE Marking and FDA Submission: Eases the process of product registration and regulatory approvals.
  7. Competitive Advantage: Differentiates your product from uncertified competitors in tenders, hospitals, and retail chains.

What kind of businesses can benefit from ISO 15197?

Market Access Expansion: Enables entry into regulated international markets, including EU, US, Japan, and Australia.

Brand Trust & Reputation: ISO 15197 signals quality, boosting customer confidence and clinical acceptance.

Reduced Product Recalls: Minimizes risk of non-compliance and technical failures, saving cost and reputation damage.

Faster Regulatory Approval: Simplifies approval processes under CE marking and other national regulatory bodies.

Investor & Partner Confidence: Certified quality attracts investors, medical distributors, and institutional partners.

Operational Efficiency: Streamlines your production, testing, and quality assurance systems.

Increased Sales Potential: Builds consumer trust in OTC markets and strengthens your competitive positioning.

Support for Future Innovations: Lays the groundwork for compliance in future IVD product developments.

Whatsapp